Cytokines in malignant lymphomas: Review and prospective evaluation

Human Pathology

Volumn 24, Issue 10, 1993, Pages 1040-1057

  Hsu, Su Ming ^a   Waldron Jr , James W ^a   Hsu, Pei Ling ^a   Hough Jr , Aubrey J ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

cytokine; Hodgkin's disease; lymphoma; review

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; B CELL LYMPHOMA; CELL DIFFERENTIATION; CELLULAR IMMUNITY; FIBROSIS; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNE DEFICIENCY; IMMUNOCYTOMA; LARGE CELL LYMPHOMA; LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SECRETION; REED STERNBERG CELL; REVIEW; T CELL LYMPHOMA; TUMOR GROWTH;

CELL DIVISION; CYTOKINES; GIANT LYMPH NODE HYPERPLASIA; HODGKIN DISEASE; HUMAN; IMMUNE TOLERANCE; LYMPHOMA; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027421048     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/0046-8177(93)90183-H     Document Type: Review

References (151)

1. The Seventeenth Century
2. Lymphatische Geschwülste
3. Blut, Knochenmark, Lymphknoten, Milz, Blutkrankheiten
4. Cytokines: Coordinators of immune and inflammatory responses
5. Cytokines in disease
6. Growth and differentiation factors for B and T cells
7. Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity
8. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF)
9. Interleukin-1 and its biologically related cytokines
10. Interleukin-9 expression in human malignant lymphoma: Unique association with Hodgkin's disease and large cell anaplastic lymphoma
11. Growth factors in Hodgkin's disease
12. Production of tumor necrosis factor-α and lymphotoxin (TNF-β) by cells of Hodgkin's neoplastic cell lines HDLM-1 and KM-H2
13. Functional heterogeneity and pathologic significance of interleukin-6 in B-cell lymphomas
14. Interleukin 1 enhances T-dependent immune responses by amplifying the function of dendritic cells
15. Accessory function of interleukin-1 and interleukin-6: Preferential costimulation of T4 positive lymphocytes
16. Interleukin-2-induced production of interferon-γ by resting human T cells and large granular lymphocytes: Requirement for accessory cell factors, including interleukin-1
17. Regulatory effects of transforming growth factor-β on IL-2- and IL-4-dependent T cell-cycle progression
18. IL-1α induces expression of active transforming growth factor-β in nonproliferating T cells via a post-transcriptional mechanism
19. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth
20. Soluble cytokine receptors: Their role in immunoregulation
21. Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease
22. Functional heterogeneity and pathogenic significance of interleukin-6 in B-cell lymphomas
23. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6
24. The spectrum of Ki-1-positive cutaneous lymphomas
25. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression
26. Expression of interleukin 1 in H-RS cells and neoplastic cells from true histiocytic lymphomas
27. Expression of interleukin-1 in Reed-Sternberg cells
28. Heterogeneity of interleukin 1 production in cultured Reed-Sternberg cell lines HDLM-1, HDLM-1d, and KM-H2
29. Interleukin-4 is the principal autocrine growth promoting factor of the L-428 Reed-Sternberg cells
30. Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia
31. Interleukin 6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease
32. Expression of macrophage colonystimulating factor (M-CSF) in two Hodgkin's Reed-Sternberg (H-RS) cell lines, HDLM-1 and KM-H2, and in H-RS cells in tissues
33. Expression of the macrophage growth factor, CSF-1 and its receptor c-fms by a Hodgkin's disease-derived cell line and its variants
34. Production of colonystimulating factors by Hodgkin's cell lines
35. Production of transforming growth factor-beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth
36. Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease
37. Production of transforming growth factor β1 and β2 by Hodgkin's Reed-Sternberg cells in Hodgkin's disease
38. Cytokine production (IL-1, IL-1β, and TNF-α) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas: An immunocytochemical study
39. Phenotypic expression of Hodgkin and Reed-Sternberg cells in Hodgkin's disease
40. Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth
41. Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures
42. Neoplastic cells obtained from Hodgkin's disease function as accessory cells for mitogen-induced human T cell proliferative responses
43. Interleukin-1-independent activation of human T lymphocytes stimulated by anti-CD3 and a Hodgkin's disease cell line with accessory cell activity
44. Modulation of keratinocyte-derived interleukin-8 which is chemotactic for neutrophils and T lymphocytes
45. A novel neutrophil chemoattractant generated during an inflammatory reaction in the rabbit peritoneal cavity in vivo. Purification, partial amino acid sequence and structural relationship to interleukin 8
46. Intraperitoneal injection of human recombinant neutrophil-activating factor/interleukin 8 (hrNAF/IL-8) produces a T cell and eosinophil infiltrate in the guinea pig lung. Effect of PAF antagonist WEB2086
47. Interferon-γ, the activated macrophage, and host defence against microbial challenge
48. Biological properties and molecular biology of the human macrophage growth factor, CSF-1
49. Partial purification of an immunosuppressive protein from a human tumor cell line and analysis of its relationship to transforming growth factor β
50. Platelet-derived growth factor-BB and transforming growth factor β1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds
51. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis
52. Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor α (TNF-α) and a synthetic TNF-α 31–68 peptide
53. Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
54. Hodgkin's disease presenting with the histological features of Castleman's disease
55. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease
56. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice
57. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease
58. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes
59. Interaction between serum factors and T lymphocytes in patients with Hodgkin's disease
60. Prostaglandin producing suppressor cells in Hodgkin's disease
61. Abnormal phytohemag-glutinin-induced T-cell proliferative responses in Hodgkin's disease
62. + cells
63. Immune deficiency in Hodgkin's disease: A study of patients and healthy relatives in families with multiple cases
64. Defective in vitro immunoglobulin production in response to pokeweed mitogen in patients with Hodgkin's disease pretreatment and in remission
65. 2 in long-term remission patients
66. + T cells showing abnormal recognition of DR antigens in lymphoid organs involved by Hodgkin's disease
67. Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes
68. β Transforming growth factors are potential regulators of B lymphocytes
69. Effects of transforming growth factor β on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness
70. Expression of PGH sythetase (cyclooxygenase) in Hodgkin's mononuclear and Reed-Sternberg cells: Functional resemblance between H-RS cells and histiocytes or interdigitating reticulum cells
71. Stimulation by phorbol ester of 15-HETE synthesis in Hodgkin cell line (KM-H2) is related to cell differentiation
72. Expression of p55 (Tac) interleukin-2 receptor (IL-2R), but not p75 IL-2R, in cultured H-RS cells and H-RS cells in tissues
73. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease
74. Lack of effect of colony-stimulating factors, interleukins, interferons, and tumor necrosis factor on the growth and differentiation of cultured Reed-Sternberg cells: Comparison with effects of phorbol ester and retinoic acid
75. Expression of both chains (p55 and p70) of the interleukin 2 receptor in Hodgkin's disease
76. Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells
77. Production of a monoclonal antibody specific for Hodgkin and Reed-Sternberg cells of Hodgkin's disease and a subset of normal lymphoid cells
78. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells
79. Molecular cloning and expression of a receptor for human tumor necrosis factor
80. Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor
81. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor
82. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor
83. Two tumor necrosis factor-binding proteins purified from human urine
84. A new superfamily of cell surface proteins related to the nerve growth factor receptor
85. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes—A molecule related to nerve growth factor receptor
86. cDNA sequences of two inducible T-cell clones
87. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas
88. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
89. Vaccinia virus homologues of the shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family
90. Modulation of human B-cell activation with workshop monoclonal antibodies to B-cell-associated differentiation antigens
91. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity
92. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF
93. Human B lymphocytes: Property, proliferation, and differentiation
94. CD40—A cytokine receptor in search of a ligand
95. The distinct surface of human blood dendritic cells
96. Molecular and biological characterization of a murine ligand for CD40
97. Tumor progression in a CD30+ cutaneous T cell lymphoma correlates with loss of type I and II receptors for grow inhibition by transforming growth factor-beta (TGF-β)
98. Transforming growth factor-beta mediates regression of skin lesions in lymphomatoid papulosis and Ki-1+ cutaneous lymphomas
99. Pathologic concentrations of interleukin 6 inhibit T cell responses via induction of activation of TGF-β
100. The cultured Reed-Sternberg cells HDLM-1 and KM-H2 can be induced to become histiocyte-like cells: H-RS cells are not derived from lymphocytes
101. Phenotypes and phorbol ester-induced differentiation of human histiocytic lymphoma cell lines (U-937 and SU-DHL-1) and Reed-Sternberg cells
102. Extracellular matrix does not induce the proliferation, but promotes the differentiation of Hodgkin's cell line HDLM-1
103. Tumour necrosis factor as an autocrine tumour growth factor for chronic B cell malignancies
104. Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia
105. Interleukin 6 gene expression in normal and neoplastic B cells
106. Spontaneous production of interleukin 1 activity by chronic lymphocytic leukemic cells
107. Human recombinant IL-6/B cell stimulatory factor 2 augments murine antigen-specific antibody responses in vitro and in vivo
108. Positive effects of interferon α on B cell type chronic lymphocytic leukemia proliferative response
109. Antiproliferative effect of interleukin 4 in B chronic lymphocytic leukemia
110. Interleukin 4 counteracts the interleukin 2-induced proliferation of monoclonal B cells
111. Lymphoplasmacytic/lymphoplasmacytoid immunocytoma with a high content of epithelioid cells. Histologic and immunohistochemical findings
112. Recombinant interleukin (IL) 2-induced human B cell differentiation is mediated by autocrine IL 6
113. IL-6 and tumor necrosis factor-α: Autocrine and paracrine cytokines involved in B cell function
114. Interleukin 6 dependence of spontaneous in vitro differentiation of B cells from patients with IgM gammapathy
115. CD8+ lymphocytes from patients with systemic lupus erythematosus sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support autoantibody synthesis
116. Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus
117. The role of IL-6 in the pathogenesis of Castleman's disease
118. Expression of GST in normal or reactive lymphoid tissues and malignant lymphomas
119. Interleukin 3 is a growth factor for human follicular B cell lymphoma
120. Chinese hamster ovarian cells transfected with the murine with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice
121. T-cell-rich B-cell lymphomas: A clinicopathologic study of 19 cases
122. Interleukin-4 may contribute to the abundant T-cell reaction and paucity of neoplastic B cells in T-cell rich B cell lymphomas
123. High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia
124. Serum levels of tumor necrosis factor-α in hairy cell leukemia
125. Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders
126. Further phenotypic evidence that nodular, lymphocyte-predominant Hodgkin's disease is a large B-cell lymphoma in evolution
127. Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma): A variant of the B-cell-derived nodular type
128. Clinical correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin's disease
129. Nodular paragranuloma and progressively transformed germinal centers. Ultrastructural and immunohistologic findings
130. Acute lymphoblastic leukemia and non-Hodgkin's lymphoma of T lineage: Colony-forming cells retain growth factor (interleukin 2) dependence
131. Production of growth factors by malignant lymphoma cell lines
132. Autonomous growth and tumorigenicity induced by P40/interleukin 9 cDNA transfection of a mouse P40-dependent T cell line
133. Expression of different combinations of interleukins by human T cell leukemic cell lines that are clonally related
134. Leukemic cells from some adult T-cell leukemia patients proliferate in response to interleukin-4
135. Interleukin 4 and gamma-interferon may play a role in the histopathogenesis of peripheral T-cell lymphoma
136. Interleukin-6 (B-cell stimulatory factor 2)-dependent growth of a Lennert's lymphoma-derived T-cell line (KT-3)
137. + lymphoma cell line derived from a patient with so-called Lennert's lymphoma: Possible roles of cytokines in histopathogenesis
138. Immunohistochemistry in lymphomas. Review and outlook
139. Skin exudate levels of interleukin 6, interleukin 1 and other cytokines in mycosis fungoides
140. Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice
141. Immunoblastic lymphadenopathy, angio immunoblastic lymphadenophathy, and IBL-like T-cell lymphoma: A spectrum of T-cell neoplasia
142. Histopathology and immunohistochemistry of peripheral T-cell lymphomas: A proposal for their classification
143. Angioimmunoblastic lymphadenopathy type of T-cell lymphoma with a high content of epithelioid cells: Histopathology and comparison with lymphoepithelioid cell lymphoma
144. Characteristic karyotypic pattern in T-cell lymphoproliferative disorders with reactive “angioimmunoblastic lymphadenopathy with dysproteinemia-type” features
145. Angioimmunoblastic lymphadenopathy with dysproteinemia
146. Significance of interleukin-6 in angioimmunoblastic lymphadenopathy (AILD)-type T cell lymphoma
147. Lymphomatoid papulosis: A continuing self-healing eruption, clinically-benign histologically-malignant
148. The clinical and histological spectrum of lymphomatoid papulosis
149. Host response in lymphomatoid papulosis